Last reviewed · How we verify

NCT04431843

the Efficacy and Safety of Spirulina Maxima Extract on Improvement of Cognitive Function

Completed NA Last updated 10 February 2023
What this trial tests

NA trial testing Spirulina maxima extract in Cognitive Function in 80 participants. Completed in 26 November 2020.

Timeline
17 March 2020
Primary endpoint
26 November 2020
26 November 2020

Quick facts

Lead sponsorChonbuk National University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment80
Start date17 March 2020
Primary completion26 November 2020
Estimated completion26 November 2020
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Chonbuk National University Hospital

Who can join

60 and older, any sex, with Cognitive Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was the evaluate the efficacy and safety of Spirulina maxima extract on the improvement of Cognitive Function

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cognitive Function

Currently open trials in the same condition.

Other Chonbuk National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04431843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing